Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

226 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Open-label study of ademetionine for the treatment of intrahepatic cholestasis associated with alcoholic liver disease.
Ivashkin VT, Maevskaya MV, Kobalava ZD, Uspenskiy YP, Fominih JA, Rozanov AV, Tolkacheva VV, Sotnikova TI, Alikhanov BA, Gorbacheva IA, Ershova OB, Znakhyrenko AA, Sokolov KA, Sander-Struckmeier S. Ivashkin VT, et al. Minerva Gastroenterol Dietol. 2018 Sep;64(3):208-219. doi: 10.23736/S1121-421X.18.02461-3. Epub 2018 Feb 8. Minerva Gastroenterol Dietol. 2018. PMID: 29431335
Sofosbuvir/velpatasvir for the treatment of HCV: excellent results from a phase-3, open-label study in Russia and Sweden.
Isakov V, Chulanov V, Abdurakhmanov D, Burnevich E, Nurmukhametova E, Kozhevnikova G, Gankina N, Zhuravel S, Romanova S, Hyland RH, Lu S, Svarovskaia ES, McNally J, Brainard DM, Ivashkin V, Morozov V, Bakulin I, Lagging M, Zhdanov K, Weiland O. Isakov V, et al. Infect Dis (Lond). 2019 Feb;51(2):131-139. doi: 10.1080/23744235.2018.1535186. Epub 2018 Nov 30. Infect Dis (Lond). 2019. PMID: 30499360 Clinical Trial.
Differential diagnosis of ascites in internal medicine: clinical case.
Tikhonov IN, Zharkova MS, Maevskaya MV, Zozulya VN, Nekrasova TP, Arslanyan MG, Musina NP, Tatarkina MA, Rzaev RT, Puzakov KB, Ivashkin VT, Malikova MS. Tikhonov IN, et al. Among authors: ivashkin vt. Ter Arkh. 2018 Aug 27;90(8):74-80. doi: 10.26442/terarkh201890874-80. Ter Arkh. 2018. PMID: 30701950
Ursodeoxycholic acid as a means of preventing atherosclerosis, steatosis and liver fibrosis in patients with nonalcoholic fatty liver disease.
Nadinskaia M, Maevskaya M, Ivashkin V, Kodzoeva K, Pirogova I, Chesnokov E, Nersesov A, Kaibullayeva J, Konysbekova A, Raissova A, Khamrabaeva F, Zueva E. Nadinskaia M, et al. World J Gastroenterol. 2021 Mar 14;27(10):959-975. doi: 10.3748/wjg.v27.i10.959. World J Gastroenterol. 2021. PMID: 33776366 Free PMC article. Clinical Trial.
Correlation of Objective Endpoints and Subjective Patient-Reported Outcomes in NAFLD Treatment with Essential Phospholipids: Real-World Data Based on Pooled Analysis of Observational Studies.
Ivashkin VT, Maevskaya MV, Shirokova EN, Maev IV, Samsonov AA, Sas EI, Palgova LK, Starostin K. Ivashkin VT, et al. Drugs Real World Outcomes. 2021 Sep;8(3):369-382. doi: 10.1007/s40801-021-00250-x. Epub 2021 May 15. Drugs Real World Outcomes. 2021. PMID: 33993460 Free PMC article.
226 results